Christopher M. Counter

20.9k citations

117 papers · 16.2k indexed · 9 hit papers · h-index 53

Impact in

Aging top 0.1%
- Genetics, Aging, and Longevity in Model Organisms
Physiology top 0.1%
- Telomeres, Telomerase, and Senescence

Papers in

Aging 6
Physiology 41
- Telomeres, Telomerase, and Senescence 36

Co-authors: Robert A. Weinberg Silvia Bacchetti Roderick L. Beijersbergen William C. Hahn Kian‐Huat Lim Calvin B. Harley Mary W. Brooks Ante S. Lundberg
Journals: Cancer Research (13 papers)Journal of Biological Chemistry (9 papers)Molecular and Cellular Biology (9 papers)PLoS ONE (8 papers)Nature Communications (6 papers)
Partner nations: United States Canada Australia

In The Last Decade

Christopher M. Counter

113 papers receiving 15.9k citations

Hit Papers

9 papers align trajectories log scale

Erk2 Phosphorylation of Drp1 Promotes Mitochondrial Fission and MAPK-Driven Tumor Growth 2015 · 538 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Molecular Cell
2014 Nature
2004 Nature Cell Biology
1999 Nature
1998 Proceedings of the National Academy of Sciences
1997 Cell
1995 Blood
1994 Cold Spring Harbor Symposia on Quantitative Biology
1992 The EMBO Journal

Peers

Countries citing papers authored by Christopher M. Counter

Since Specialization

Citations

This map shows the geographic impact of Christopher M. Counter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Counter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Counter more than expected).

Fields of papers citing papers by Christopher M. Counter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Counter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Counter. The network helps show where Christopher M. Counter may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christopher M. Counter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher M. Counter Line = papers co-authored together Christopher M. Counter links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Exploiting codon usage identifies intensity-specific modifiers of Ras/MAPK signaling in vivo PLoS Genetics ·Jessica K. Sawyer, Zahra Kabiri, Ruth A. Montague, 政昭米村, Gene Jensen, 昌秀金, Erez Cohen, Hamed Zaribafzadeh, Christopher M. Counter, Donald T. Fox	2020	6
2	Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer Clinical Cancer Research ·Mengmeng Xu, Nurul Mu’azzah Abdul Latif, K. Cenzual, Julie Ann Sosa, Christopher M. Counter	2018	54
3	Codon usage regulates human KRAS expression at both transcriptional and translational levels Journal of Biological Chemistry ·Jingjing Fu, Yunkun Dang, Christopher M. Counter, Yi Liu	2018	40
4	Wnt signaling suppresses MAPK-driven proliferation of intestinal stem cells Journal of Clinical Investigation ·Zahra Kabiri, Gediminas Greicius, Hamed Zaribafzadeh, Amanda Hemmerich, Christopher M. Counter, David M. Virshup	2018	65
5	Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability Nature Communications ·E Aikäs, Christopher M. Counter	2018	66
6	Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors Cancer Research ·Donita C. Brady, Matthew S. Crowe, M. A. Ryblova, Christopher M. Counter	2017	126
7	Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer PLoS ONE ·K. P. Verma, Benjamin L. Lampson, Magdaléna Drotárová, Hsin Liang Huang, Diana M. Cardona, Christopher M. Counter	2015	10
8	Erk2 Phosphorylation of Drp1 Promotes Mitochondrial Fission and MAPK-Driven Tumor Growth Molecular Cell ·Jennifer A. Kashatus, Michel Euriat, Lindsey J. Myers, F. Stürtzbecher, Frances L. Byrne, Kyle L. Hoehn, Christopher M. Counter, David F. Kashatus Hit paper breakdown →	2015	538
9	A Genetic Porcine Model of Cancer PLoS ONE ·Lawrence B. Schook, Tiago Collares, Wenping Hu, Ying Liang, Fernanda Martins Rodrigues, Laurie A. Rund, Kyle M. Schachtschneider, Fabiana K. Seixas, Kuldeep Singh, Kevin D. Wells, Eric M. Walters, Randall S. Prather, Christopher M. Counter	2015	116
10	Copper is required for oncogenic BRAF signaling and tumorigenesis Molecular Cancer Research ·Donita C. Brady, L PETROVIC, Michelle L. Turski, 幸雄駒井, نبيل كامل محمد دخان, A. Chaikuad, Stefan Knapp, Ke Xiao, Gauri Arolkar, Dennis J. Thiele, Christopher M. Counter	2014	1
11	Cell Cycle Regulated Phosphorylation of the Telomere-Associated Protein TIN2 PLoS ONE ·Lisa Torrieri, Christopher M. Counter	2013	3
12	Targeting eNOS in Pancreatic Cancer Cancer Research ·Benjamin L. Lampson, Yaroslav Kichuk, Brooke B. Ancrile, Meghan M. Morrison, Fikrunnia Adi Prasojo, Igna Luciara Raffaeli Albino, Matthew S. Crowe, David F. Kashatus, Rebekah R. White, Susan B. Gurley, Diana M. Cardona, Christopher M. Counter	2012	56
13	Ral activation promotes melanomagenesis Oncogene ·Patricia A. Zipfel, Donita C. Brady, David F. Kashatus, Brooke Ancrile, Douglas S. Tyler, Christopher M. Counter	2010	37
14	ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis Carcinogenesis ·Kevin O’Hayer, Donita C. Brady, Christopher M. Counter	2009	31
15	The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis Cancer Research ·Yi-Shan Lee, Kian‐Huat Lim, Xingrong Guo, Yoshiharu Kawaguchi, Ya‐sheng Gao, Tomasa Barrientos, Peter Ordentlich, Xiao‐Fan Wang, Christopher M. Counter, Tso‐Pang Yao	2008	220
16	Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma Cancer Research ·Мария Андреевна Понятая, Katherine T. Etheridge, Stacey J. Adam, Stephen J. Qualman, Rex C. Bentley, Christopher M. Counter, Corinne M. Linardic	2008	61
17	DNA-based Animal Models of Human Disease: from Genotype to Phenotype PubMed ·Lawrence B. Schook, 忠則図所, Stacey J. Adam, Laurie A. Rund, Kefei Chen, Margarita B. Rogatcheva, А. В. Куркина, Fatima Driouech, Christopher M. Counter	2008	12
18	Genetic induction of tumorigenesis in Swine Oncogene ·Stacey J. Adam, Laurie A. Rund, 忠則図所, James F. Zachary, Lawrence B. Schook, Christopher M. Counter	2006	43
19	Characterization of Interactions between PinX1 and Human Telomerase Subunits hTERT and hTR Journal of Biological Chemistry ·Soma S. R. Banik, Christopher M. Counter	2004	60
20	C-Terminal Regions of the Human Telomerase Catalytic Subunit Essential for In Vivo Enzyme Activity Molecular and Cellular Biology ·Soma S. R. Banik, Chuanhai Guo, Emigdio Melquiades Zavaleta Cabrera, Seth S. Margolis, WM Alcocer Rosado, Carlos A Tirado, Christopher M. Counter	2002	83

About Christopher M. Counter

Christopher M. Counter is a scholar working on Aging, Physiology, Molecular Biology, Biotechnology and Oncology, having authored 117 papers that have together received 16.2k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (36 papers), Cancer-related Molecular Pathways (17 papers), DNA Repair Mechanisms (16 papers), Protein Kinase Regulation and GTPase Signaling (13 papers), CRISPR and Genetic Engineering (11 papers), Melanoma and MAPK Pathways (10 papers), Cancer Research and Treatments (10 papers) and Animal Genetics and Reproduction (10 papers). The work is most often cited by research in Aging (880 citations), Physiology (7.0k citations), Biotechnology (1.4k citations), Molecular Biology (10.1k citations) and Oncology (3.2k citations). Christopher M. Counter has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Robert A. Weinberg, Silvia Bacchetti, Roderick L. Beijersbergen, William C. Hahn, Kian‐Huat Lim, Calvin B. Harley, Mary W. Brooks, Ante S. Lundberg, Carol W. Greider and Matthew Meyerson. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Molecular and Cellular Biology, PLoS ONE and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact